Clinical Trials Browser

Unknown × anlotinib × Genitourinary × Clear all

NCT05030077 2021-09-01

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT02072044 2017-12-29

Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy

Phase 2 Unknown

Carcinoma, Renal Cell